Deutsche Bank
EVOK

Deutsche Bank’s Evoke Pharma EVOK Stock Holding History

Deutsche Bank’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3
Closed -$1K – 4654
2021
Q1 		$1K Hold
3
– – ﹤0.01% 4517
2020
Q4 		$1K Buy
+3
New +$1.55K ﹤0.01% 4383
2018
Q2 		– Sell
-1,389
Closed -$416K – 5465
2018
Q1 		$416K Hold
1,389
– – ﹤0.01% 3809
2017
Q4 		$452K Buy
+1,389
New +$576K ﹤0.01% 3653
2017
Q3 		– Sell
-1
Closed – – 4937
2017
Q2 		$0 Sell
1
-9
-90% -$3.45K ﹤0.01% 4990
2017
Q1 		$4K Buy
+10
New +$4.1K ﹤0.01% 4723
2015
Q3 		– Sell
-7
Closed -$5K – 5230
2015
Q2 		$5K Buy
+7
New +$5.96K ﹤0.01% 5148
2015
Q1 		– Sell
-3
Closed -$2K – 5333
2014
Q4 		$2K Buy
+3
New +$2.48K ﹤0.01% 6003

Other funds holding EVOK

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deutsche Bank's EVOK Position: Q2 2021 in Review

Deutsche Bank sold out of Evoke Pharma (EVOK) in Q2 2021, closing a stake of 3 shares — an estimated $1K sold.

Deutsche Bank first reported a position in EVOK in Q4 2014 and held it in 8 quarters. The position peaked at $452K in Q4 2017. 19 funds tracked by Wall St. Rank hold EVOK as of Q2 2021.

  • Deutsche Bank reported no remaining Evoke Pharma position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 3 Evoke Pharma shares in Q2 2021, an estimated $1K.
  • Deutsche Bank first reported a position in Evoke Pharma in Q4 2014 and held it in 8 quarters.
  • Deutsche Bank's Evoke Pharma position peaked at $452K in Q4 2017.
  • 19 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.